PHILADELPHIA, Aug. 24, 2023 /PRNewswire/ — Carisma Therapeutics Inc. (Nasdaq: CARM) (“Carisma” or the “Company”), a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the Company will present at two healthcare industry conferences in September 2023. These conferences include: A replay of webcasts, when…Read More
Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in September 2023
